BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1048@pharmaconomics
DTSTAMP:20260707T010020Z
DTSTART;VALUE=DATE:20260715
DTEND;VALUE=DATE:20260716
SUMMARY:INMB PDUFA — CORDStrom
DESCRIPTION:The FDA's approval decision on CORDStrom for Recessive Dystrophic Epidermolysis Bullosa (RDEB) is due Jul 15\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1711754/000121390026008204/ea027431701ex99-1_inmune.htm\n\nTrack it: https://www.pharmaconomics.com/e/1048
URL:https://www.pharmaconomics.com/e/1048
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INMB catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR